As we work to fulfil our mission to help adult smokers switch from combustible cigarettes, JUUL Labs is committed to both conducting and supporting durably designed, painstakingly executed preclinical, clinical, and behavioural research examining the public health impact of our products. We occupy a unique space in this industry as we seek to completely eliminate combustible cigarettes by providing smokers an alternative nicotine delivery system.
For the full story, please visit our US Newsroom at newsroom.juul.com
November 8, 2024
Juul Labs Inc. has announced the appointment of Melissa Wisdom as its new Managing Director. The appointment comes as the Company continues to drive…
June 22, 2023
The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…
January 26, 2023
Juul Labs’ JUUL2 system has been awarded Product of the Year 2023 in the ‘Vaping & Heated Tobacco Products’ category, following an independent nationwide…